SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001739104-20-000023
Filing Date
2020-11-06
Accepted
2020-11-06 16:12:02
Documents
87
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q elan-20200930.htm   iXBRL 10-Q 1896812
2 EX-31.1 ex311elanco-20200930xceoce.htm EX-31.1 9963
3 EX-31.2 ex312elanco-20200930xcfoce.htm EX-31.2 9966
4 EX-32 ex32elanco-20200930xsectio.htm EX-32 7440
  Complete submission text file 0001739104-20-000023.txt   9161676

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT elan-20200930.xsd EX-101.SCH 56696
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT elan-20200930_cal.xml EX-101.CAL 102167
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT elan-20200930_def.xml EX-101.DEF 393118
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT elan-20200930_lab.xml EX-101.LAB 718692
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT elan-20200930_pre.xml EX-101.PRE 532637
10 EXTRACTED XBRL INSTANCE DOCUMENT elan-20200930_htm.xml XML 1613252
Mailing Address 2500 INNOVATION WAY GREENFIELD IN 46140
Business Address 2500 INNOVATION WAY GREENFIELD IN 46140 877-352-6261
Elanco Animal Health Inc (Filer) CIK: 0001739104 (see all company filings)

IRS No.: 825497352 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38661 | Film No.: 201294538
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences